Multifunctional mesoporous silica nanoparticles (MSN) have attracted substantial attention with regard to their high potential for targeted drug delivery. For future clinical applications it is crucial to address safety concerns and understand the potential immunotoxicity of these nanoparticles. In this study, we assess the biocompatibility and functionality of multifunctional MSN in freshly isolated, primary murine immune cells. We show that the functionalized silica nanoparticles are rapidly and efficiently taken up into the endosomal compartment by specialized antigen-presenting cells such as dendritic cells. The silica nanoparticles showed a favorable toxicity profile and did not affect the viability of primary immune cells from the spleen in relevant concentrations. Cargo-free MSN induced only very low immune responses in primary cells as determined by surface expression of activation markers and release of pro-inflammatory cytokines such as Interleukin-6, -12 and -1β. In contrast, when surfacefunctionalized MSN with a pH-responsive polymer capping were loaded with an immuneactivating drug, the synthetic Toll-like receptor 7 agonist R848, a strong immune response was provoked. We thus demonstrate that MSN represent an efficient drug delivery vehicle to primary immune cells that is both non-toxic and non-inflammagenic, which is a prerequisite for the use of these particles in biomedical applications.
INTRODUCTION
In recent years the development of nanoparticles for various biomedical applications has been the focus of intense research. 1 Rationally designed nanoparticles are engineered for targeted delivery of various drugs or vaccines. 2 With spatio-temporally controlled release of their therapeutic cargo, such nanoparticles have the potential to increase drug efficacy while minimizing undesired off-target effects. However, due to their nanoscale size, chemical composition and surface reactivity, nanoparticles can be potentially detected by and interact with the host immune response. 3 While in certain applications (e.g. vaccine delivery) an immunostimulatory function may be desirable, 4 uncontrolled systemic immune activation will limit their therapeutic use. Thus, the profound understanding of a nanomaterial's interaction with the immune system and its possible stimulatory and suppressive actions are a critical prerequisite for any clinical application.
Specialized antigen-presenting cells (APC) of the innate immune system, such as dendritic cells (DC), constantly sample their surroundings, taking up cell debris and foreign materials.
These cells are equipped with a variety of pattern-recognition receptors that allow for the detection of invading pathogens or signs of cell stress and damage. Ligation of these receptors results in maturation of APCs associated with expression of costimulatory molecules (such as CD80 and CD86), the release of proinflammatory cytokines and eventually the initiation of a subsequent adaptive immune response. 5 DCs have been shown to efficiently engulf various kinds of nanoparticles both in vitro and in vivo, 6, 7 but the consequences with regard to subsequent immune responses remain poorly understood.
Previous work of some of us has been focused on the development of a portfolio of coreshell colloidal mesoporous silica nanoparticles. 8, 9 Due to their different molecular functionalization in the core and the shell, the MSN can be equipped with internal functionality for controlled host-guest interactions, a system for accurate cargo release upon external stimuli, as well as targeting ligands towards the required type of cell. A broad variety of different triggered-release capping systems were presented in the past years, based on external stimuli such as light 10, 11 , heat, 12 or magnetic fields, 13 or triggered by intracellular events including a change in pH, 14, 15 redox reactions, 16 or the presence of enzymes. 17 For example, we recently reported a multifunctional system based on a pH-responsive polymer (poly(2-vinylpyridine), MSN-PVP) that allows for the facile delivery of membrane-permeable cargos into cancer cells. 18 With the possibility to integrate almost any functionality of interest, as well as the efficient synthesis, this system holds promise for wide-ranging biological and medical applications, especially in cancer therapy. agonist R848 (Invivogen, Toulouse). All chemicals were used as received without further purification. Doubly distilled water from a Millipore system (Milli-Q Academic A10) was used for all synthesis and purification steps.
Preparation of shell-functionalized colloidal mesoporous silica nanoparticles. Polymercapped mesoporous silica nanoparticles (MSN-PVP) were synthesized as described previously. 8, 18 In brief, colloidal MSN with an amino-functionality (MSN-NH 2 ) were prepared by a delayed co-condensation approach with cetyltrimethylammonium chloride (CTAC) as structure directing agent and tetraethylorthosilicate (TEOS) as primary silica source. 8 In order to introduce the outer shell functionalization, 3-aminotriethoxysilane (APTES) was added during the condensation process. The synthesis was followed by a facile extraction of the organic template from the mesopores. Then, 50 mg of the template-extracted MSN-NH 2 were subsequently reacted with a boc-protected bi-functional polymer (COOH-PVP-NHboc) dissolved in THF in an EDC-assisted amidation reaction. The reaction was followed by the deprotection of the polymer with trifluoroacetic acid, yielding the sample MSN-PVP. measurements were performed on a Malvern Zetasizer-Nano instrument equipped with a 4 mW He-Ne laser (633 nm) and an avalanche photodiode. The hydrodynamic radius of the particles was determined by dynamic light scattering in ethanolic or aqueous suspension. For this purpose, 100 µL of an ethanolic suspension of MSN particles (ca. 10 mg/mL) was diluted with 3 mL of ethanol or water prior to the measurement. Zeta potential measurements of the samples were performed on a Malvern Zetasizer-Nano instrument equipped with a 4 mW HeNe laser (633 nm) and an avalanche photodiode. Zeta potential measurements were performed using the add-on Zetasizer titration system (MPT-2) based on diluted NaOH and HCl as titrants. For this purpose, 1 mg of the particles was diluted in 10 mL bi-distilled water.
Thermogravimetric analysis was performed on a Netzsch STA 440 C TG/DSC with a heating rate of 10 K / min in a stream of synthetic air of about 25 mL/min. The mass was normalized to 100% at 150 °C for all samples to take into account solvent desorption.
Mice. Female C57Bl/6 mice were purchased from Harlan-Winkelmann. Mice were at 6-8
weeks of age at the time of the experiment. Animal studies were approved by the local regulatory agency (Regierung von Oberbayern, Munich, Germany). NPs, washed and re-suspended in culture medium. 75 nM LysoTracker (Invitrogen) and 3 µg/mL Hoechst dye (Invitrogen) were used for lysosomal and nuclear staining. Stained cells were visualized using a confocal laser scanning microscope (TCS SP5II, Leica).
Media
Statistics. All data are presented as mean ± S.E.M. Statistical significance of single experimental findings was assessed with the independent two-tailed Student's t-test. For multiple statistical comparison of a data set the one-way ANOVA test with Bonferroni post-test was used. Significance was set at p-values p < 0.05, p < 0.01 and p < 0.001 and was then indicated with an asterisk (*, ** and ***). All statistical calculations were performed using Graphpad Prism (GraphPad Software).
RESULTS

MSN particle characteristics.
As reported previously, 18 the template-free MSN-NH 2 show a wormlike pore structure with an average pore size of 3.8 nm and feature a large surface area (1097 m 2 /g) which is typical for MSN (Table 1 and The inorganic-organic hybrid material consists of a mesoporous silica core (grey) and a covalently attached pH-responsive polymer (poly(2-vinylpyridine), blue).
The covalent modification of MSN-NH 2 with a boc-protected poly(2-vinylpyridine) and the following de-protection was monitored with several characterization methods; the accessible pore size as determined by nitrogen sorption measurements is barely affected by the surface modification with the pH-responsive polymer, whereas the decrease of the specific surface area is relatively large. This can be explained by the addition of non-porous polymer to the outer surface and the blocking of some pores by frozen polymer on the surface layer of the MSN. Dynamic light scattering (DLS) measurements in aqueous media revealed an average particle size of 160 nm for MSN-NH 2 and 550 nm for MSN-PVP. The polymer-modified sample shows some aggregation behaviour in water due to the hydrophobicity at pH 7, indicated by the apparent size increase to 550 nm. However, transmission electron microscopy (TEM) revealed that the polymer-functionalized sample MSN-PVP still features a narrow particle size distribution, which makes them excellent candidates as drug delivery vehicles. 
MSN-NH 2 are non-toxic and do not affect the viability of splenocytes, unless used in very high concentrations
We next sought to determine the cytotoxicity of MSN for primary cells. For this purpose, freshly isolated splenocytes were cultured in the presence of increasing concentrations of MSN-NH 2 and 18 hours later, we performed Annexin V / propidium iodide (PI) analysis by flow cytometry. Annexin V binds to phosphatidylserins, which in apoptotic cells are translocated from the inner to the outer leaflet of the plasma membrane, and are thus exposed to the external cellular environment. 20 PI is a small molecule that intercalates into double-stranded DNA and becomes fluorescent upon intercalation. PI can only reach nuclear DNA when the cell's integrity is severely compromised during late apoptosis and cell death.
The gating strategy for early and late apoptotic cells is depicted in the representative dot blot (Fig. 3A) . MSN-NH 2 showed a favorable (low) toxicity profile in primary cells and induced released only low amounts of IL-6 and IL-12p70 (Fig. 4B) . Crystalline silica (found in nature as sand or quartz) have been shown to activate a cytosolic multi-protein complex called the NALP3 inflammasome resulting in the release of bioactive IL-1β, a very potent proinflammatory cytokine. 22 In contrast, MSN-NH 2 only induced trace levels of IL-1β (Fig. 4C) . In summary, these data demonstrate that MSN-NH 2 only mildly activate primary murine APCs. 
Bystander lymphoid cells are not stimulated by mesoporous silica nanoparticles
T and B lymphocytes are the effector cells of the adaptive immune system. We have shown that these cell types do not efficiently take up MSN-FITC and are thus unlikely to directly recognize these nanoparticles (Fig. 3A,B) . However, T and B cells may react to low levels of pro-inflammatory cytokines released by antigen-presenting cells in response to MSN. In order to investigate the immunostimulatory effect of MSN on such bystander lymphocytes, complete splenocytes (containing both antigen-presenting cells and lymphocytes) were cultured in the presence of MSN-NH 2 and expression of the transmembrane C-type lectin CD69, an early activation marker on B and T cells, was analyzed by flow cytometry. We found that neither B nor T cells showed upregulation of the activation marker CD69 (Fig. 5) , indicating that the low-level cytokine release by antigen-presenting cells in response to MSN-NH 2 is not sufficient for activation of bystander lymphocytes. In summary, our findings show that MSN-NH 2 are rapidly taken up into specialized antigen-presenting cells but are non-toxic and only weakly immunostimulatory to primary murine immune cells. to contact hypersensitivity. 28 However, treatment of mice with MSN over a time course of several weeks resulted in histological changes in liver and spleen. 29 We note that such findings are expected to be very dependent on the size, surface functionalization and zeta potential of the particles and thus cannot be generalized for different types of MSN.
Generally, the impact of repetitive treatments with MSN must be carefully evaluated before long-term clinical applications are conducted.
Crystalline silica have been shown to potently activate the NLRP3 inflammasome, a cytosolic multiprotein complex, triggering the release of the bioactive form of the potent proinflammatory cytokine IL-1β. 30 Similar to crystalline silica, non-functionalized, amorphous silica nanoparticles can activate the inflammasome, leading to significant IL-1β secretion. 31 In
contrast, here we demonstrate that the molecularly functionalized MSN-NH 2 particles do not induce relevant levels of IL-1β release from primary murine splenocytes. Initial reports suggested that phagocytosis of crystalline silica with a median particle size of 5 µm results in presumably osmotic swelling and damage of the lysosome, leading to activation of the NALP3 inflammasome, which is triggered by lysosomal rupture and content release, not the crystal structure itself. 30 While others linked the formation of reactive oxygen species during an oxidative stress situation to NLRP3 activation, 32 the exact molecular mechanism and prerequisite for inflammasome activation remains to be determined. We propose that due to their size and molecularly functionalized surface structure, spherical MSN-NH 2 in comparison to silica crystals do not induce lysosomal damage and subsequent inflammasome-mediated IL-1β release. Generally, besides the physicochemical properties of particle size and surface chemistry, the biological activity of MSN has also been attributed to shape features such as aspect ratio and morphology. Interestingly, MSN have been described to enhance MHC class I-restricted presentation of antigens by human dendritic cells. 42 This process called cross-presentation is a vital prerequisite for the induction of adaptive T-cell immunity against exogenous antigens such as tumor proteins. We found that the functionalized MSN-NH 2 without protein or adjuvant cargo do not interact with or activate T-and B-lymphocytes in vitro. These findings underline the important role of dendritic cells at the interface of innate and adaptive immunity.
Importantly, the lack of unspecific lymphocyte priming by the MSN carrier system is a promising requisite for future in vivo applications in order to use the high specificity of molecular immunostimulants either on the surface of the MSN or delivered as cargo from its pore system.
Generally, the application of immunostimulatory adjuvants or vaccines via MSN harbors the risk of undesired systemic inflammatory responses upon the uptake of cargo-loaded MSN and subsequent cargo release. These dangerous adverse events can possibly be circumvented by context-dependent, spatiotemporally controlled cargo release. We and other groups pursue a promising approach that takes advantage of internal triggers such as an intracellular change in pH. 14, 15 The efficient pH-responsive closing and opening mechanism of a reversible polymer cap system has been previously demonstrated by time-based fluorescence release experiments; fluorescent dyes were used in these studies. 18, 43 In this work, the synthetic TLR7 agonist R848 (resiquimod) was used as active cargo. R848-loaded MSN-PVP particles induced strong activation of dendritic cells with potent release of proinflammatory cytokines. As a defined ligand for endosomal TLR7/8, R848 was presumably released after pH-dependent reopening of the mesopores in the endosome. Whether such spatially controlled release can augment the efficacy and regulation of the subsequent immune response is the focus of ongoing research. Similarly, temporally defined release of the MSN-PVP cargo also appears attractive, as the kinetics of receptor sensitivity strongly influence the outcome of R848-based cancer immunotherapy. 44 In summary, we demonstrate in this study that MSN-NH 2 nanoparticles are non-toxic to primary murine leukocytes and provoke only trace immune activation. In addition, surface functionalized MSN-PVP can serve as a pH-triggered drug delivery tool for the synthetic TLR7/8 ligand R848 to induce potent immune activation in responder cells. The controlled release of their immunomodulatory cargo by otherwise non-immunogenic MSN is a promising tool in future therapies in order to achieve localized immune activation (e.g. in the tumor microenvironment) while preventing undesired, systemic adverse effects.
